eli lilly tirzepatide cease and desist letter just issued a public warning to the compounding industry. In a recent open letter, the pharmaceutical company raised concerns about products being combined with vitamin B12 marketed in Eli Lilly sues Mochi Health

Future prospective studies with robust control groups and mechanistic studies are needed to elucidate how semaglutide may influence NAION risk, including its effects on optic nerve perfusion, microcirculation, and endothelial function

Subcutaneous injection delivers nearly 100% of the administered dose to systemic circulation

Semaglutides Alzheimers Trial Failure: Rethinking Molecular Targets Beyond Amyloid Abstract Novo Nordisks recent phase 3 trials of semaglutide in early Alzheimers disease failed to demonstrate meaningful cognitive benefits, despite initial optimism and some biomarker improvements

I think bariatric surgery is underutilized

Proper technique is crucial to reduce discomfort and ensure the medications effectiveness